BRIEF published on 04/30/2026 at 18:35, 5 months 3 days ago Oxurion Releases 2025 Annual Report and Convenes Shareholders' Meeting Shareholders' Meeting Annual Report Oxurion Financial Year 2025 Pharmaceutical Outsourcing
PRESS RELEASE published on 04/30/2026 at 18:30, 5 months 3 days ago Publication Annual Report - Annual Shareholders Meeting Oxurion NV releases annual report for FY2025 at its Annual Shareholders' Meeting in Leuven, Belgium. Details available on website. Specializes in pharmaceutical outsourcing Shareholders' Meeting Annual Report Belgium Oxurion NV Pharmaceutical Outsourcing
BRIEF published on 04/16/2026 at 18:05, 5 months 17 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Euronext Brussels Atlas Special Opportunities Oxurion NV
BRIEF published on 04/16/2026 at 18:05, 5 months 17 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Transparency Digital Assets Participations Investments Oxurion
PRESS RELEASE published on 04/16/2026 at 18:00, 5 months 17 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing threshold under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 04/07/2026 at 18:05, 5 months 26 days ago Oxurion Postpones Annual Shareholders Meeting Financial Calendar Shareholders Meeting Investment Risks Oxurion Pharmaceutical Outsourcing
BRIEF published on 04/07/2026 at 18:05, 5 months 26 days ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
PRESS RELEASE published on 04/07/2026 at 18:00, 5 months 26 days ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 6 months 15 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
BRIEF published on 03/19/2026 at 18:35, 6 months 15 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
Published on 10/03/2026 at 02:35, 22 hours 14 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 10 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 9 hours 4 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 4 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 5 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 6 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 7 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 5 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 6 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 6 hours ago Covivio - Information on total number of voting rights and share capital
